-
BH3 Mimetics Target Senescent Breast Cancer Cells
2026-09-13
The reference study shows that chemotherapy-induced senescent breast cancer cells can remain viable, secrete tumor-promoting factors, and become selectively vulnerable to BH3 mimetics targeting BCL-2 family survival proteins. Its combination of cell-state profiling, genetic validation, and mouse studies provides a rationale for eliminating residual TP53-wild-type tumor cells after chemotherapy.
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-09-12
Phosphatase Inhibitor Cocktail (2 Tubes, 100X) is a dual-component system for limiting post-collection dephosphorylation during lysate preparation. It is intended for immunoblotting, immunoprecipitation, kinase assays, and mass spectrometry workflows, but it does not replace rapid harvesting, temperature control, or assay-specific compatibility testing.
-
Vitamin C in Cancer and HEV Organoid Research
2026-09-11
Vitamin C and ascorbic acid can be evaluated more rigorously when concentration, tissue context, and assay endpoints are aligned. This article connects model-specific oncology evidence with a multilineage HEV organoid platform while defining practical limits for antiviral translation.
-
Estradiol, ER Signaling, and CD4+ T-Cell Recovery
2026-09-11
The reference study shows that 17β-estradiol restores splenic CD4+ T-lymphocyte proliferation and cytokine production after hemorrhagic shock by attenuating endoplasmic reticulum stress through ERα and GPR30, rather than ERβ. Its receptor-selective pharmacology and stress-induction experiments provide a useful framework for interpreting how estrogen signaling regulates post-traumatic immune dysfunction.
-
Prochlorperazine-Induced Neuroleptic Malignant Syndrome
2026-09-10
This case report documents neuroleptic malignant syndrome after standard-dose prochlorperazine in a 76-year-old man, emphasizing that severe clinical features may occur without marked leukocytosis or creatine phosphokinase elevation. The report also shows how prompt recognition, medication withdrawal, benzodiazepine therapy, and amantadine supported recovery.
-
Steroid Lysis of Protoplasts and Membrane Mechanisms
2026-09-10
Smith and Shay used osmotically fragile Sarcina lutea protoplasts to separate cell-wall effects from direct membrane injury by synthetic antimicrobial steroids. Their protection, antagonism, and optical lysis experiments support membrane-directed antimicrobial activity while also defining important limits for applying this assay logic to modern fungal infection research.
-
Deferoxamine Mesylate in Redox Translation
2026-09-09
Deferoxamine mesylate is more than a conventional iron-chelating agent: it is a mechanistic tool for separating iron-dependent oxidative injury from hypoxia signaling. This thought-leadership guide shows how translational researchers can use it to interrogate redox biology, HIF-1α stabilization, tumor growth inhibition in breast cancer, and tissue-protection workflows without overstating preclinical evidence.
-
A23187, free acid: Reliable Cell Assays
2026-09-09
A scenario-driven guide to using A23187, free acid (SKU B6646) as a calcium ionophore in viability, proliferation, cytotoxicity, and apoptosis workflows. It connects formulation, controls, protocol design, and dual viability metrics to improve interpretation and experimental reliability.
-
CLCC1 in Herpesvirus Nuclear Egress
2026-09-08
The bioRxiv preprint identifies CLCC1 as an essential host factor for the membrane-fusion step that releases herpes simplex virus 1 capsids from the nuclear envelope. Its CRISPR-screening and cell-biology data connect herpesvirus nuclear egress with nuclear pore insertion, providing a mechanistic framework for studying host-directed antiviral strategies while leaving direct biochemical fusion activity unresolved.
-
2'-O-Methyladenosine: Assay Workflows
2026-09-08
Build more reliable RNA modification and purine metabolism experiments with 2'-O-Methyladenosine as an authentic analyte, dosing reagent, and method-development standard. The workflow connects controlled cell exposure with matrix-aware UHPLC–MS/MS, helping distinguish biological changes from ion suppression, isomer interference, and sample instability.
-
Quercetin Workflows for PI3K and Ferroptosis Research
2026-09-07
Build a reproducible Quercetin workflow that connects PI3K signaling, apoptosis, mitochondrial dysfunction, and ferroptosis without relying on a single endpoint. Practical dosing, assay-selection, and troubleshooting guidance helps researchers translate the Wilson’s disease liver-injury findings into cancer research and cell-based studies.
-
CDK4/6 Inhibition Beyond G1 Arrest
2026-09-07
PD 0332991 and Palbociclib HCl offer a precise way to interrogate CDK4/6–Rb biology, but emerging pancreatic cancer evidence shows why cell-cycle control must be evaluated alongside invasion, EMT, and pathway adaptation. This thought-leadership analysis connects mechanistic rigor with translational study design.
-
Simvastatin (Zocor): Applied Research Workflows
2026-09-05
Build reproducible Simvastatin workflows for lipid-metabolism studies, hepatic cancer models, and membrane-focused experiments. This guide connects solvent handling and dose selection with orthogonal apoptosis, cell-cycle, and bilayer assays.
-
CCCP for Mitochondrial Morphology Assays
2026-09-04
Learn how CCCP can create a controlled mitochondrial proton gradient disruption for live-cell imaging, bioenergetics, and morphology workflows. This practical guide connects CCCP optimization with urine-derived stem cell assays inspired by a recent deep-learning study of Alzheimer’s disease–associated mitochondrial patterns.
-
α-Bungarotoxin: Blocking Receptors, Testing Translation
2026-09-04
α-Bungarotoxin is more than a receptor antagonist: it is a causal pharmacology tool for testing whether α7 nicotinic acetylcholine receptor signaling connects cholinergic activity with tissue injury, inflammation, and necroptosis. This article translates recent placental findings into practical guidance for neuroscience and translational research workflows.